HALIFAX, NS, Aug. 17 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,
NASDAQ: MMIRF) a global market leader in premium rapid diagnostic solutions,
announced today that it has received product approval and the first order from
its new Colombian agent, the IKXUR Company (IKXUR). MedMira will immediately
ship 20,000 tests against a total order for 220,000 MiraWell(R) Rapid HIV
Tests (MiraWell HIV). The balance of the order will be filled in quarterly
shipments over the next year.
